Digestive & Intestinal Remedies (Pharmacies) - Malaysia

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$69.79m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.22%, resulting in a market volume of US$90.01m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$2.01 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Malaysia is experiencing steady growth due to customer preferences for natural and herbal remedies, increasing awareness about digestive health, and a growing aging population.

Customer preferences: Customers in Malaysia are increasingly opting for natural and herbal remedies for digestive and intestinal issues. This preference is driven by a growing awareness of the potential side effects of synthetic medications and a desire for more holistic approaches to healthcare. As a result, there is a rising demand for products made from natural ingredients such as ginger, peppermint, and aloe vera, which are believed to have digestive benefits.

Trends in the market: The market for Digestive & Intestinal Remedies in Malaysia is witnessing a shift towards preventive care. Consumers are becoming more proactive in managing their digestive health and are seeking products that can prevent or alleviate common digestive issues such as indigestion, bloating, and constipation. This trend is driving the demand for products like probiotics, fiber supplements, and herbal teas that promote healthy digestion. Another trend in the market is the increasing popularity of online sales channels. With the rise of e-commerce platforms and the convenience of online shopping, more consumers are turning to online channels to purchase Digestive & Intestinal Remedies. This trend is particularly prominent among younger consumers who are tech-savvy and prefer the convenience of shopping from the comfort of their own homes.

Local special circumstances: Malaysia has a diverse population with a mix of different ethnicities and cultures. This diversity is reflected in the variety of traditional remedies and practices for digestive health that are prevalent in the country. Traditional Malay, Chinese, and Indian medicine systems all have their own unique approaches to digestive health, and consumers in Malaysia often incorporate elements from these different traditions into their healthcare routines.

Underlying macroeconomic factors: The growing aging population in Malaysia is a key driver of the Digestive & Intestinal Remedies market. As people age, they are more prone to digestive issues such as acid reflux, gastritis, and irritable bowel syndrome. This demographic shift is increasing the demand for products that can address these specific health concerns. Additionally, rising disposable incomes in Malaysia are enabling consumers to spend more on healthcare and wellness products. As people become more health-conscious and prioritize their well-being, they are willing to invest in products that can support their digestive health. In conclusion, the Digestive & Intestinal Remedies market in Malaysia is witnessing growth due to customer preferences for natural remedies, increasing awareness about digestive health, and the demographic shift towards an aging population. The market is also influenced by trends towards preventive care and the rise of online sales channels. The diverse cultural landscape in Malaysia further contributes to the demand for a variety of traditional remedies. Overall, the market is expected to continue growing as consumers prioritize their digestive health and seek out products that can support their well-being.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.